GMAT Question of the Day - Daily to your Mailbox; hard ones only

It is currently 18 Sep 2018, 06:44

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Close

Request Expert Reply

Confirm Cancel

The government health service has said that it definitely will not pay

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:

Hide Tags

Director
Director
avatar
V
Joined: 30 Jan 2016
Posts: 706
Location: United States (MA)
Reviews Badge CAT Tests
The government health service has said that it definitely will not pay  [#permalink]

Show Tags

New post 20 Feb 2018, 10:23
1
2
00:00
A
B
C
D
E

Difficulty:

  45% (medium)

Question Stats:

59% (01:23) correct 41% (01:34) wrong based on 191 sessions

HideShow timer Statistics

The government health service has said that it definitely will not pay for patients to take the influenza medicine Antinfia until the drug's manufacturer, PharmCo, provides detailed information about Antinfia's cost effectiveness. PharmCo has responded that obtaining such information would require massive clinical trials. These trials cannot be performed until the drug is in widespread circulation, something that will happen only if the goverrunent health service pays for Antinfia.

If the statements of both the government health service and PharmCo are true, which one of the following is most likely to also be true?

(A) The goverrunent health service never pays for any medicine unless that medicine has been shown to be cost-effective.
(B) Antinfia will never be in widespread circulation.
(C) If the government health service does not pay for Antinfia, then many patients will pay for Antinfia themselves.
(D) The government health service should pay for patients to take Antinfia.
(E) Antinfia is not cost-effective.

Source: LSAT

_________________

Non progredi est regredi

Board of Directors
User avatar
P
Joined: 01 Sep 2010
Posts: 3466
Re: The government health service has said that it definitely will not pay  [#permalink]

Show Tags

New post 20 Feb 2018, 10:29
Top Contributor
Due to its circular reasoning, the only valid option is B. Actually, the drug will not be on the market.

However, notice how this is for LSAT but is not so much suitable for GMAT. The wording of an official question (especially in the latest OGs) is quite different.

Regards
_________________

COLLECTION OF QUESTIONS AND RESOURCES
Quant: 1. ALL GMATPrep questions Quant/Verbal 2. Bunuel Signature Collection - The Next Generation 3. Bunuel Signature Collection ALL-IN-ONE WITH SOLUTIONS 4. Veritas Prep Blog PDF Version 5. MGMAT Study Hall Thursdays with Ron Quant Videos
Verbal:1. Verbal question bank and directories by Carcass 2. MGMAT Study Hall Thursdays with Ron Verbal Videos 3. Critical Reasoning_Oldy but goldy question banks 4. Sentence Correction_Oldy but goldy question banks 5. Reading-comprehension_Oldy but goldy question banks

VP
VP
User avatar
V
Status: It's near - I can see.
Joined: 13 Apr 2013
Posts: 1255
Location: India
Concentration: International Business, Operations
GMAT 1: 480 Q38 V22
GPA: 3.01
WE: Engineering (Consulting)
Premium Member Reviews Badge CAT Tests
The government health service has said that it definitely will not pay  [#permalink]

Show Tags

New post 11 Apr 2018, 23:55
    Akela wrote:
    The government health service has said that it definitely will not pay for patients to take the influenza medicine Antinfia until the drug's manufacturer, PharmCo, provides detailed information about Antinfia's cost effectiveness. PharmCo has responded that obtaining such information would require massive clinical trials. These trials cannot be performed until the drug is in widespread circulation, something that will happen only if the goverrunent health service pays for Antinfia.

    If the statements of both the government health service and PharmCo are true, which one of the following is most likely to also be true?

    (A) The goverrunent health service never pays for any medicine unless that medicine has been shown to be cost-effective.
    (B) Antinfia will never be in widespread circulation.
    (C) If the government health service does not pay for Antinfia, then many patients will pay for Antinfia themselves.
    (D) The government health service should pay for patients to take Antinfia.
    (E) Antinfia is not cost-effective.

    Source: LSAT


    Not able to understand and infer properly. Though this is an LSAT question, there must me correct reasoning for the right answer.

    Please help and also let us know whether such questions can be tested on GMAT or not.

    VeritasPrepKarishma, GMATNinja
    _________________

    "Do not watch clock; Do what it does. KEEP GOING."

    Veritas Prep GMAT Instructor
    User avatar
    P
    Joined: 16 Oct 2010
    Posts: 8278
    Location: Pune, India
    Re: The government health service has said that it definitely will not pay  [#permalink]

    Show Tags

    New post 12 Apr 2018, 01:08
    1
    QZ wrote:
      Akela wrote:
      The government health service has said that it definitely will not pay for patients to take the influenza medicine Antinfia until the drug's manufacturer, PharmCo, provides detailed information about Antinfia's cost effectiveness. PharmCo has responded that obtaining such information would require massive clinical trials. These trials cannot be performed until the drug is in widespread circulation, something that will happen only if the goverrunent health service pays for Antinfia.

      If the statements of both the government health service and PharmCo are true, which one of the following is most likely to also be true?

      (A) The goverrunent health service never pays for any medicine unless that medicine has been shown to be cost-effective.
      (B) Antinfia will never be in widespread circulation.
      (C) If the government health service does not pay for Antinfia, then many patients will pay for Antinfia themselves.
      (D) The government health service should pay for patients to take Antinfia.
      (E) Antinfia is not cost-effective.

      Source: LSAT


      Not able to understand and infer properly. Though this is an LSAT question, there must me correct reasoning for the right answer.

      Please help and also let us know whether such questions can be tested on GMAT or not.

      VeritasPrepKarishma, GMATNinja


      Yes, the reasoning is proper.

      Argument tells us:

      - Govt says it will not pay for Antinfia until PharmCo provides details on cost effectiveness.
      - PharmCo says it can provide these details only if the Govt pays for Antinfia.

      So basically they are caught in a circle. Hence, if both these statements are assumed to be true, the Govt will not pay for Antinfia and it will never be in widespread circulation (since the Govt needs to pay for it to be in widespread circulation). So (B) is correct.

      (A) The goverrunent health service never pays for any medicine unless that medicine has been shown to be cost-effective.
      We don't know this. We only know that they have refused to pay for Antinfia until its cost effectiveness is proven.

      (C) If the government health service does not pay for Antinfia, then many patients will pay for Antinfia themselves.
      We don't know what patients will do. Out of scope.

      (D) The government health service should pay for patients to take Antinfia.
      Should or should not is not our call. We need to find what is true according to argument.

      (E) Antinfia is not cost-effective.
      The argument doesn't say that. PharmCo just needs widespread circulation to prove that it is cost-effective.
      _________________

      Karishma
      Veritas Prep GMAT Instructor

      Learn more about how Veritas Prep can help you achieve a great GMAT score by checking out their GMAT Prep Options >

      GMAT self-study has never been more personalized or more fun. Try ORION Free!

      Manager
      Manager
      User avatar
      B
      Joined: 03 Apr 2016
      Posts: 98
      Location: India
      Concentration: General Management, Leadership
      Schools: ISB '19, IIMB
      GMAT 1: 580 Q43 V27
      GMAT 2: 650 Q32 V48
      GRE 1: Q160 V151
      GPA: 3.99
      WE: Design (Consulting)
      GMAT ToolKit User Reviews Badge CAT Tests
      Re: The government health service has said that it definitely will not pay  [#permalink]

      Show Tags

      New post 12 Apr 2018, 10:07
      Akela wrote:
      The government health service has said that it definitely will not pay for patients to take the influenza medicine Antinfia until the drug's manufacturer, PharmCo, provides detailed information about Antinfia's cost effectiveness. PharmCo has responded that obtaining such information would require massive clinical trials. These trials cannot be performed until the drug is in widespread circulation, something that will happen only if the goverrunent health service pays for Antinfia.

      If the statements of both the government health service and PharmCo are true, which one of the following is most likely to also be true?

      (A) The goverrunent health service never pays for any medicine unless that medicine has been shown to be cost-effective.
      (B) Antinfia will never be in widespread circulation.
      (C) If the government health service does not pay for Antinfia, then many patients will pay for Antinfia themselves.
      (D) The government health service should pay for patients to take Antinfia.
      (E) Antinfia is not cost-effective.

      Source: LSAT


      The stimulus basically means, government doesn't give money if the drug is not cost effective and company can't say the drug is cost effective until government gives money. So they have reached an impasse. This means the drug will never get a widespread circulation. option B.
      Re: The government health service has said that it definitely will not pay &nbs [#permalink] 12 Apr 2018, 10:07
      Display posts from previous: Sort by

      The government health service has said that it definitely will not pay

        new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  

      Events & Promotions

      PREV
      NEXT


      GMAT Club MBA Forum Home| About| Terms and Conditions and Privacy Policy| GMAT Club Rules| Contact| Sitemap

      Powered by phpBB © phpBB Group | Emoji artwork provided by EmojiOne

      Kindly note that the GMAT® test is a registered trademark of the Graduate Management Admission Council®, and this site has neither been reviewed nor endorsed by GMAC®.